Toshiyasu Taniguchi

13.1k total citations · 3 hit papers
83 papers, 9.8k citations indexed

About

Toshiyasu Taniguchi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Toshiyasu Taniguchi has authored 83 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 27 papers in Cancer Research and 26 papers in Oncology. Recurrent topics in Toshiyasu Taniguchi's work include DNA Repair Mechanisms (42 papers), Carcinogens and Genotoxicity Assessment (16 papers) and BRCA gene mutations in cancer (12 papers). Toshiyasu Taniguchi is often cited by papers focused on DNA Repair Mechanisms (42 papers), Carcinogens and Genotoxicity Assessment (16 papers) and BRCA gene mutations in cancer (12 papers). Toshiyasu Taniguchi collaborates with scholars based in United States, Japan and United Kingdom. Toshiyasu Taniguchi's co-authors include Alan D. D’Andrea, Markus Grompe, Elizabeth M. Swisher, Irene García-Higuera, Paul R. Andreassen, Céline Jacquemont, Beth Y. Karlan, Wataru Sakai, James Hejna and Cynthia Timmers and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Toshiyasu Taniguchi

81 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway

2001 978 citations Toshiyasu Taniguchi, Markus Grompe et al. profile →
Biallelic Inactivation of BRCA2 in Fanconi Anemia

2002 859 citations Niall G. Howlett, Toshiyasu Taniguchi et al. Science profile →
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

2008 792 citations Wataru Sakai, Elizabeth M. Swisher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toshiyasu Taniguchi United States	44	7.9k	3.5k	2.8k	2.1k	844	83	9.8k
Charles Theillet France	55	5.3k 0.7×	4.0k 1.1×	2.6k 0.9×	1.9k 0.9×	657 0.8×	140	8.7k
Yoshio Miki Japan	43	5.1k 0.6×	2.8k 0.8×	1.6k 0.6×	1.4k 0.7×	624 0.7×	155	8.0k
Jean Feunteun France	46	5.2k 0.7×	2.2k 0.6×	1.3k 0.5×	2.6k 1.2×	516 0.6×	128	7.6k
Mary Ellen Moynahan United States	34	5.2k 0.7×	3.3k 0.9×	2.0k 0.7×	1.6k 0.7×	355 0.4×	75	7.4k
Lori S. Friedman United States	42	4.8k 0.6×	2.5k 0.7×	1.1k 0.4×	1.9k 0.9×	455 0.5×	106	7.4k
Brigitte Bressac–de Paillerets France	43	3.7k 0.5×	3.5k 1.0×	2.1k 0.8×	1.5k 0.7×	431 0.5×	120	7.5k
Ian Hickson United Kingdom	16	4.8k 0.6×	4.2k 1.2×	1.0k 0.4×	996 0.5×	254 0.3×	28	6.4k
Nuala McCabe United Kingdom	19	5.1k 0.6×	5.0k 1.4×	1.2k 0.4×	1.3k 0.6×	186 0.2×	43	7.2k
Roger A. Greenberg United States	51	7.9k 1.0×	2.6k 0.7×	1.3k 0.5×	1.2k 0.6×	927 1.1×	98	10.3k
Edward A. Fox United States	33	4.8k 0.6×	1.7k 0.5×	1.2k 0.4×	1.8k 0.8×	289 0.3×	53	7.4k

Countries citing papers authored by Toshiyasu Taniguchi

Since Specialization

Citations

This map shows the geographic impact of Toshiyasu Taniguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiyasu Taniguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiyasu Taniguchi more than expected).

Fields of papers citing papers by Toshiyasu Taniguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiyasu Taniguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiyasu Taniguchi. The network helps show where Toshiyasu Taniguchi may publish in the future.

Co-authorship network of co-authors of Toshiyasu Taniguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiyasu Taniguchi. A scholar is included among the top collaborators of Toshiyasu Taniguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiyasu Taniguchi. Toshiyasu Taniguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kanao, Rie, Hidehiko Kawai, Toshiyasu Taniguchi, Minoru Takata, & Chikahide Masutani. (2022). RFWD3 and translesion DNA polymerases contribute to PCNA modification–dependent DNA damage tolerance. Life Science Alliance. 5(12). e202201584–e202201584. 7 indexed citations

Li, Xueli, Toshiyasu Taniguchi, Keith R. Johnson, et al.. (2019). CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. Cell Death Discovery. 5(1). 105–105. 14 indexed citations

Dhillon, Kiranjit K., Ilirjana Bajrami, Toshiyasu Taniguchi, & Christopher J. Lord. (2016). Synthetic lethality: the road to novel therapies for breast cancer. Endocrine Related Cancer. 23(10). T39–T55. 14 indexed citations

Wang, Yemin, Jen‐Wei Huang, María Castellà, David G. Huntsman, & Toshiyasu Taniguchi. (2014). p53 Is Positively Regulated by miR-542-3p. Cancer Research. 74(12). 3218–3227. 52 indexed citations

Huang, Jen‐Wei, Yemin Wang, Kiranjit K. Dhillon, et al.. (2013). Systematic Screen Identifies miRNAs That Target RAD51 and RAD51D to Enhance Chemosensitivity. Molecular Cancer Research. 11(12). 1564–1573. 81 indexed citations

Wang, Yemin, Jen‐Wei Huang, Philamer Calses, Christopher J. Kemp, & Toshiyasu Taniguchi. (2012). MiR-96 Downregulates REV1 and RAD51 to Promote Cellular Sensitivity to Cisplatin and PARP Inhibition. Cancer Research. 72(16). 4037–4046. 103 indexed citations

Wang, Yemin, Jen‐Wei Huang, Ming Li, et al.. (2011). MicroRNA-138 Modulates DNA Damage Response by Repressing Histone H2AX Expression. Molecular Cancer Research. 9(8). 1100–1111. 121 indexed citations

Dhillon, Kiranjit K., Elizabeth M. Swisher, & Toshiyasu Taniguchi. (2010). Secondary mutations of BRCA1/2 and drug resistance. Cancer Science. 102(4). 663–669. 113 indexed citations

Sakai, Wataru, Elizabeth M. Swisher, Céline Jacquemont, et al.. (2009). Functional Restoration of BRCA2 Protein by Secondary BRCA2 Mutations in BRCA2 -Mutated Ovarian Carcinoma. Cancer Research. 69(16). 6381–6386. 242 indexed citations

10.

Swisher, Elizabeth M., Wataru Sakai, Beth Y. Karlan, et al.. (2008). Secondary BRCA1 Mutations in BRCA1 -Mutated Ovarian Carcinomas with Platinum Resistance. Cancer Research. 68(8). 2581–2586. 346 indexed citations

11.

Jacquemont, Céline & Toshiyasu Taniguchi. (2007). Proteasome Function Is Required for DNA Damage Response and Fanconi Anemia Pathway Activation. Cancer Research. 67(15). 7395–7405. 163 indexed citations

12.

Chen, Clark C., Toshiyasu Taniguchi, & Alan D. D’Andrea. (2007). The Fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents. Journal of Molecular Medicine. 85(5). 497–509. 69 indexed citations

13.

Taniguchi, Toshiyasu, Barbara Cox, Yassmine Akkari, et al.. (2006). Natural gene therapy in monozygotic twins with Fanconi anemia. Blood. 107(8). 3084–3090. 61 indexed citations

14.

Howlett, Niall G., Toshiyasu Taniguchi, Sandra G. Durkin, Alan D. D’Andrea, & Thomas W. Glover. (2005). The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Human Molecular Genetics. 14(5). 693–701. 232 indexed citations

15.

Howlett, Niall G., Toshiyasu Taniguchi, Susan B. Olson, et al.. (2002). Biallelic Inactivation of BRCA2 in Fanconi Anemia. Science. 297(5581). 606–609. 859 indexed citations breakdown →

16.

Nakanishi, Koji, et al.. (2001). Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells. Experimental Hematology. 29(12). 1448–1455. 32 indexed citations

17.

Taniguchi, Toshiyasu, Akira Fujita, Shunji Takahashi, et al.. (1998). Cyclin D1 Overexpression Detected by a Simple Competitive Reverse Transcription‐polymerase Chain Reaction Assay for Lymphoid Malignancies. PubMed Central. 89(2). 159–166. 12 indexed citations

18.

Tamura, Takeshi, Masahiko Ishihara, Marc S. Lamphier, et al.. (1997). DNA damage-induced apoptosis and Ice gene induction in mitogenically activated T lymphocytes require IRF-1.. PubMed. 11 Suppl 3. 439–40. 32 indexed citations

19.

Nagata, Toshiko, et al.. (1990). [A case of lupus cystitis complicated by membranous lupus nephritis].. PubMed. 79(6). 820–1. 4 indexed citations

20.

Tsudo, Mitsuru, Hajime Karasuyama, Fujiko Kitamura, et al.. (1990). The IL-2 receptor beta -chain (p70). Ligand binding ability of the cDNA-encoding membrane and secreted forms.. The Journal of Immunology. 145(2). 599–606. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact